A microfluidic device includes at least one microchannel with a plurality of micropillar arrays provided along a length of the microchannel. Each micropillar array defines a plurality microcapillaries having cross sectional area, and the cross sectional area of the microcapillaries defined by each micropillar array decreases in a direction of fluid flow through the microchannel.

A blood glucose test strip includes a base substrate, a calibration site, a test site and a non-volatile memory. The calibration site is disposed on the base substrate. A chemical reagent is applied on the calibration site. The test site is disposed on the base substrate. A chemical reagent is applied on the test site. The non-volatile memory is disposed on the base substrate. A calibration parameter is stored in the non-volatile memory. During a calibrating procedure, the calibration solution is dropped on the calibration site, a calibration parameter is calculated according to a first reaction result of the calibration solution and the chemical reagent, and the calibration parameter is stored in the non-volatile memory.

Systems and methods are provided for sample collection from one or more subjects using mobile sample collection devices.

Devices, methods and systems related to wearable patch having blood alcohol content detector. In some embodiments, a wearable patch can include a patch structure having one or more layers and configured to allow the patch to be worn by a user, and an analyzer component implemented on or at least partially within the patch structure and configured to measure alcohol content level in the user. The wearable patch can further include an interface component implemented on or at least partially within the patch structure and in communication with the analyzer component, with the interface component being configured to provide a notification based on the measured alcohol content. In some embodiments, such a wearable patch can be a part of a system such as a monitoring system or a compliance system.

Provided herein are devices and methods for extracting blood plasma from ultra-low volumes of blood. In some cases, the devices and methods use positive pressure to force a blood sample through a filter or a membrane. In some cases, the devices and methods use centrifugation to force a blood sample through a filter or a membrane. The devices and methods disclosed herein are suitable for the preparation of high-quality samples containing cell-free nucleic acids.

A system is provided for monitoring analyte in a host, including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. In one embodiment, the device includes a single point analyte monitor, from which it obtains an analyte value, and is configured to display only single point analyte measurement values, and not any analyte measurement values associated with data received from the continuous analyte sensor. Instead, data received from the continuous analyte sensor is used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. In another embodiment, the device provides for toggling between two modes, with one mode that allows for display of glucose concentration values associated with the continuous glucose sensor and a second mode that prevents the display of glucose concentration values associated with the continuous glucose sensor.

Devices and methods for withdrawing bodily fluid from a patient are disclosed herein. A handheld device configured in accordance with the present technology can include a housing having an opening, a skin-piercing assembly located at least partially within the housing, and an actuator movable relative to the housing along a deployment direction. The skin-piercing assembly can include a skin-piercing feature and a biasing member. The biasing member can be coupled to the skin-piercing feature to bias the skin-piercing feature along the deployment direction. Movement of the actuator along the deployment direction to a predetermined position can increase a load on the biasing member to at least a partially loaded state. Movement of the actuator along the deployment direction beyond the predetermined position can release the load on the biasing member so that the biasing member actively drives the skin-piercing feature along the deployment direction.

A dermal patch for collecting a physiological sample includes a housing with a collection chamber, a sample channel and a pin within a receptacle of the housing. The sample channel is configured to direct a physiological sample drawn from a subject to the collection chamber. The pin is removably positioned within the receptacle and is configured to move from an undeployed position to a deployed position. The pin is configured to seal the receptacle when in the undeployed position and is further configured to facilitate generation of negative pressure in the sample channel when the pin is moved from the undeployed to the deployed position.

A blood glucose detection device and system are portable blood glucose detection devices for patients. The blood glucose detection device includes a plurality of lancing units, which collect patient blood and generate current. The test unit can detect the current and transmit the current intensity data to the external device, thus making the glucose detection device portable. Besides, there is no need to change test strips every time for a blood glucose test as the current intensity data can be transmitted externally for management, which improves the patient's experience and makes it convenient for patients to perform blood glucose tests when they go out.

In one aspect, a dermal patch is disclosed, which comprises at least one needle configured for puncturing a subject's skin so as to allow drawing blood from the subject, a first blood-transfer fluidic channel for receiving at least a portion of the drawn blood, and a serum-separation element fluidly coupled to said first blood-transfer fluidic channel for receiving at least a portion of the drawn blood and separating a serum component thereof. In some embodiments, the dermal patch may include at least one reservoir for storing blood-processing reagent(s).